Hypermarcas (OTCMKTS:HYPMY) Sees Unusually-High Trading Volume Following Better-Than-Expected Earnings

Hypermarcas (OTCMKTS:HYPMY) saw strong trading volume on Friday following a better than expected earnings announcement. Approximately 58,852 shares changed hands during mid-day trading, an increase of 165% from the previous session’s volume of 22,179 shares.The stock last traded at $4.20 and had previously closed at $4.1275.

The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%.

Wall Street Analyst Weigh In

A number of analysts have commented on HYPMY shares. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. Zacks Research upgraded Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy”.

Hypermarcas Stock Performance

The firm has a market cap of $2.96 billion, a PE ratio of 8.75 and a beta of 0.70. The firm’s 50 day moving average price is $4.10 and its two-hundred day moving average price is $4.36.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.